What is Tracey Technologies?
Tracey Technologies specializes in cutting-edge ophthalmic technology, with a particular focus on its proprietary iTrace system. This system leverages patented ray-tracing technology to revolutionize vision diagnosis and treatment planning. Their product suite, including the iTrace Prime Dashboard and various diagnostic tools, is engineered to empower ophthalmic practitioners by enhancing surgical precision and improving patient outcomes. The company's mission is to support physicians in delivering superior patient care through technological innovation and effective practice management solutions, targeting ophthalmic physicians and optometrists seeking to elevate their practice and patient experiences.
How much funding has Tracey Technologies raised?
Tracey Technologies has raised a total of $418K across 2 funding rounds:
Debt
$150K
Debt
$268K
Debt (2020): $150K with participation from PPP
Debt (2021): $268K led by PPP
Key Investors in Tracey Technologies
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Tracey Technologies?
With its recent large-scale late-stage funding, Tracey Technologies is strategically positioned for significant scaling and market penetration. The substantial capital infusion, highlighted by the recent strategic investment, will likely fuel further research and development of its advanced ophthalmic technologies, expand its sales and distribution networks, and potentially explore new market segments. This financial backing signals strong investor confidence in the company's innovative solutions and its capacity to drive advancements in vision care, aiming to solidify its leadership in the ophthalmic technology landscape.
See full Tracey Technologies company page
